Type 2 diabetes (T2D) is characterized by a progressive decline in the β-cell function with a parallel reduction in insulin secretion that gradually raises hyperglycemia despite glucose-lowering medication [1,2]. The gene discussed is INS; the disease is type 2 diabetes mellitus.